A pcDNA-Ehcpadh vaccine against Entamoeba histolytica elicits a protective Th1-like response in hamster liver

Vaccine

Volumn 27, Issue 31, 2009, Pages 4176-4186

  Martínez, Máximo B ^a   Rodríguez, Mario A ^b   García Rivera, Guillermina ^b   Sánchez, Tomás ^b   Hernández Pando, Rogelio ^c   Aguilar, Diana ^c   Orozco, Esther ^b  

^a UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Amoebiasis; DNA vaccine; Entamoeba histolytica; Gene expression

Indexed keywords

ADHESIN; CYSTEINE PROTEINASE; DNA VACCINE; GAMMA INTERFERON; GENE PRODUCT; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERLEUKIN 4; PROTEIN EHADH112; PROTEIN EHCP112; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMEBIASIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFICACY; EHADH112 GENE; EHCP112 GENE; EHCPADH GENE; ENTAMOEBA HISTOLYTICA; GENE; GENETIC TRANSCRIPTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; INOCULATION; LIVER ABSCESS; MALE; NONHUMAN; PARASITE VIRULENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; SURVIVAL RATE; SYRIAN HAMSTER; TH1 CELL; TROPHOZOITE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CRICETINAE; CYSTEINE ENDOPEPTIDASES; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; INTERFERON-GAMMA; LIVER; MALE; MESOCRICETUS; PLASMIDS; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SURVIVAL ANALYSIS; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, DNA; VIRULENCE FACTORS;

EID: 67349241691     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.051     Document Type: Article

References (58)

1. Caballero-Salcedo A., Viveros-Rogel M., Salvatierra B., Tapia-Conyer R., Sepulveda-Amor J., Gutierrez G., et al. Seroepidemiology of amebiasis in Mexico. Am J Trop Med Hyg 4 (1994) 412-419
2. Pham V.L., Duong M.H., and Pham N.H. Amebic abscess of the liver: ultrasound guided puncture. Ann Chirurg 50 (1996) 340-343
3. Abd-Alla M.D., and Ravdin J.I. Diagnosis of amoebic colitis by antigen captures ELISA in patients presenting with acute diarrhea in Cairo, Egypt. Trop Med Int Health 7 (2002) 365-370
4. Walsh J.A. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect 8 (1986) 228-238
5. Kelsall B.L., and Ravdin J.I. Immunization of rats with the 260-kilodalton Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence-inhibitory activity. Infect Immun 63 (1995) 686-689
6. Zhang T., and Stanley Jr. S.L. Protection of gerbils from amebic liver abscess by immunization with a recombinant protein derived from the 170-kilodalton surface adhesin of Entamoeba histolytica. Infect Immun 62 (1994) 2605-2608
7. Lotter H., Khajawa F., Stanley Jr. S.L., and Tannich E. Protection of gerbils from amebic liver abscess by vaccination with a 25-mer peptide derived from the cysteine-rich region of Entamoeba histolytica galactose-specific adherence lectin. Infect Immun 68 (2000) 4416-4421
8. Dodson J.M., Lenkowski Jr. P.W., Eubanks A.C., Jackson T.F., Napodano J., Lyerly D.M., et al. Infection and immunity mediated by the carbohydrate recognition domain of the Entamoeba histolytica Gal/GalNAc lectin. J Infect Dis 179 (1999) 460-466
9. Zhang T., and Stanley Jr. S.L. Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess. Infect Immun 64 (1996) 1526-1531
10. Martínez-Gómez F., Pérez-Castillo V.L., and Talamás-Rohana P. Preliminary study of the 220 kDa lectin-elicited immune response in hamster: possible vaccine candidate. Arch Med Res 28 (1997) 267-268
11. Zhang T., and Stanley S. DNA vaccination with the serine rich Entamoeba histolytica protein (SREHP) prevents amebic liver abscess in rodents models of disease. Vaccine 18 (2000) 868-874
12. Gaucher D., and Chadee K. Construction and immunogenicity of a codon-optimized Entamoeba histolytica Gal-lectin-based DNA vaccine. Vaccine 20 (2002) 3244-3253
13. Madriz X., Martínez M.B., Rodríguez M.A., Sierra G., Martínez-López C., Riverón A.M., et al. Expression in fibroblasts and in live animals of Entamoeba histolytica polypeptides EhCP112 and EhADH112. Microbiology 150 (2004) 1251-1260
14. Zhang T., Cieslak P.R., Foster L., Kunz-Jenkins C., and Stanley S.L. Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amebic liver abscess in severe combined immunodeficient (SCID) mice. Parasite Immunol 16 (1994) 225-230
15. Lotter H., Zhang T., Seydel K.B., Stanley Jr. S.L., and Tannich E. Identification of an epitope on the Entamoeba histolytica 170-kD lectin conferring antibody-mediated protection against invasive amebiasis. J Exp Med 185 (1997) 1793-1801
16. Haque R., Ali I.M., Sack R.B., Farr B.M., Ramakrishnan G., and Petri Jr. W.A. Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. J Infect Dis 183 (2001) 1787
17. Salata R.A., and Ravdin J.I. Immunoprophylaxis. In: Ravdin J.I. (Ed). Amebiasis: human infection by Entamoeba histolytica (1988), John Wiley and Sons, New York 785-792
18. Campbell D., and Chadee K. Interleukin (IL)-2, IL-4, and tumor necrosis factor-α responses during Entamoeba histolytica liver abscess development in gerbils. J Infect Dis 175 (1997) 1176-1183
19. Houpt E.R., Glembocki J., Obrig T.G., Moskaluk C.A., Lockhart L.A., Wright R.L., et al. The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells. J Immunol 169 (2002) 4496-4503
20. Asgharpour A., Gilchrist C., Baba D., Hamano S., and Houpt E. Resistance to intestinal Entamoeba histolytica infection is conferred by innate immunity and Gr-11 cells. Infect Immun 73 (2005) 4522-4529
21. Lotter H., Jacobs T., Gaworski I., and Tannich E. Sexual dimorphism in the control of amebic liver abscess in immunocompetent mice. Infect Immun 74 (2006) 118-124
22. Gurunathan S., Dennis M., Klinman D.M., and Seder R.A. DNA vaccines: immunology, application, and optimization. Ann Rev Immunol 18 (2000) 927-974
23. Garcia-Rivera G., Rodriguez M.A., Ocadiz R., Martinez-Lopez M.C., Arroyo R., Gonzalez-Robles A., et al. Entamoeba histolytica: a novel cysteine protease and an adhesin form the 112 kDa surface protein. Mol Microbiol 33 (1999) 556-568
24. Arroyo R., and Orozco E. Localization and identification of an Entamoeba histolytica adhesin. Mol Biochem Parasitol 23 (1987) 151-158
25. Martinez-Lopez C., Orozco E., Sanchez T., Garcia-Perez R.M., Hernandez-Hernandez F., and Rodriguez M.A. The EhADH112 recombinant polypeptide inhibits cell destruction and liver abscess formation by Entamoeba histolytica trophozoites. Cell Microbiol 6 (2004) 367-376
26. Rodríguez M.A., Hernandez F., Santos L., Valdez A., and Orozco E. Entamoeba histolytica: molecules involved in the target cell-parasite relationship. Mol Biochem Parasitol 37 (1989) 87-99
27. Ocádiz R., Orozco E., Carrillo E., Quintas L.I., Ortega-López J., García-Pérez R.M., et al. EhCP112 is an Entamoeba histolytica secreted cysteine protease that may be involved in the parasite-virulence. Cell Microbiol 7 2 (2005) 221-232
28. Bañuelos C., García-Rivera G., López-Reyes I., and Orozco E. Functional characterization of EhADH112: an Entamoeba histolytica Bro1 domain-containing protein. Exp Parasitol 110 (2005) 292-297
29. Diamond L.S., Harlow D.R., and Cunnick C.C. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans Roy Soc Trop Med Hyg 72 (1978) 431-432
30. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
31. Rama Iñiguez S., Dea-Ayuela M.A., Sanchez-Brunete J.A., Torrado J.J., Alunda J.M., and Bolas-Fernández F. Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden syrian hamster infected with Leishmania infantum and treated with a new Amphotericin B formulation. Antimicrob Agents Chemother 50 4 (2006) 1195-1201
32. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) 2002-2007
33. Crispe I.N. Hepatic T cells and liver tolerance. Nat Rev Immunol 3 (2003) 51-62
34. Carter E.W., and Kerr D.E. Optimization of DNA-based vaccination in cows using green fluorescent protein and protein A as a prelude to immunization against staphylococcal mastitis. J Dairy Sci 86 4 (2003) 1177-1186
35. Boyle J.S., Koniaras C., and Lew A.M. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int Immunol 9 (1997) 1897-1906
36. Haddad D., Liljeqvist S., Stahl S., Andersson I., Perlmann P., Berzins K., et al. Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody responses in mice. FEMS Immunol Med Microbiol 18 (1997) 193-202
37. Deck R.R., DeWitt C.M., Donnelly J.J., Liu M.A., and Ulmer J.B. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine 15 (1997) 71-78
38. Robinson H.L., Boyle C.A., Feltquate D.M., Morin M.J., Santoro J.C., and Webster R.G. DNA immunization for influenza virus: studies using hemagglutinin and nucleoprotein expressing DNAs. J Infect Dis 176 (1997) S50-S55
39. Ivory C., and Chadee K. DNA vaccines: designing strategies against parasitic infections. Genet Vaccines Ther 2 (2004) 17
40. La Cava A., Billetta R., Gaietta G., Bonnin D.B., Baird S.M., and Albani S. Cell mediated DNA transport between distant inflammatory sites following intradermal DNA immunization in the presence of adjuvant. J Immunol 164 (2000) 1340-1345
41. Dupuis M., Denis-Mize K., Woo C., Goldbeck C., Selby M.J., Chen M., et al. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol 165 (2000) 2850-2858
42. Chattergoon M.A., Robinson T.M., Boyer J.D., and Weiner D.B. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J Immunol 160 (1998) 5707-5718
43. Coelho-Castelo A.A.M., Santos-Junior R.R., Bonato V.L., Jamur M.C., Oliver C., and Silva C.L. B-lymphocytes in bone marrow or lymph nodes can take up plasmid DNA after intramuscular delivery. Hum Gene Ther 14 (2003) 1279-1285
44. Forg P., von Hoegen P., Dalemans W., and Schirrmacher V. Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Ther 5 6 (1998) 789-797
45. Maeda S., Ohmori K., Kurata K., Sakaguchi M., Masuda K., Ohno K., et al. Expression of LacZ gene in canine muscle by intramuscular inoculation of a plasmid DNA. J Vet Med Sci 66 3 (2004) 337-339
46. Dai Y., Roman M., Naviaux R.K., and Verma I.M. Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci USA 89 (1992) 10892-10895
47. Zarember K.A., and Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168 (2002) 554-561
48. Thomson A.W., and Lu L. Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation 68 (1999) 1-8
49. Thomson A.W., and Lu L. Are dendritic cells the key to liver transplant tolerance?. Immunol Today 20 (1999) 27-32
50. Goddard S., Youster J., Morgan E., and Adams D.H. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol 164 (2004) 511-519
51. Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2 (2002) 151-161
52. Vercammen M., Scorza T., Huygen K., De Braekeleer J., Diet R., Jacobs D., et al. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun 68 1 (2000) 38-45
53. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20 (2002) 709-760
54. Katz S.C., Pillarisetty V.G., Bleier J.I., Kingham T.P., Chaudhry U.I., Shah A.B., et al. Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors. Hepatology 42 (2005) 293-300
55. Abe M., Akbar S.M., Horiike N., and Onji M. Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver. J Hepatol 34 (2001) 61-67
56. Kumar S., Epstein J.E., and Richie T.L. Vaccines against asexual stage malaria parasites. Malaria immunology. In: Perlmann P., and Troye-Blomberg M. (Eds). Malaria immunology. Chem Immunol vol. 80 (2002), Basel, Karger 262-286
57. Ivory C.P.A., Keller K., and Chadee K. CpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils. Infect Immun 74 (2006) 528-536
58. Marinets A., Zhang T., Guillén N., Gounon P., Bohle B., Vollmann U., et al. Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica. J Exp Med 186 9 (1997) 1557-1565